Company
Cygenica
Redefining Intracellular Therapeutic Delivery
Also known as CyGenica Limited
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Founded
- 2016
- Customers
- visionary biopharmaceutical partners
- Legal name
- CyGenica Limited
Claim, correct or request removal
Record updated 17 September 2026
About
GEENIE is a groundbreaking, engineered protein nanoneedle with a cell entry mechanism that is unique. By completely bypassing the endosomes, GEENIE ensures precise and efficient delivery of a wide range of therapeutics, from nucleotides to proteins. This next-generation technology redefines what’s possible in intracellular drug delivery.
Funding snapshot
- Total raised
- $3MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Bridge, $1.6M2025
Funding rounds
- Bridge
- $1.6M2025, Company stated
- Seed
- $1.4M2022, Company stated
Products
- Other
- GEENIE
Loading relationship preview